DSK Platinum Herbert Smith Skadden and Slaughter lead on Mylans 16 billion acquisition of Injectable unit of Strides Arcolab

DSK Platinum Herbert Smith Skadden and Slaughter lead on Mylans 16 billion acquisition of Injectable unit of Strides Arcolab

Generic drug maker Mylan Inc is acquiring injectable subsidiary of India’s Strides Arcolab for $1.6 billion (Rs.8,500 crore) in an all-cash deal to expand its presence in the fast-growing injectable drugs market.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com